2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with urocanic acid in 1 studies
| Studies (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Trials (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Recent Studies (post-2010) (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Studies (urocanic acid) | Trials (urocanic acid) | Recent Studies (post-2010) (urocanic acid) |
|---|---|---|---|---|---|
| 43 | 0 | 11 | 495 | 12 | 99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm-Wilcox, C; Bosnic, M; Cope, RB; Reeve, VE | 1 |
1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and urocanic acid
| Article | Year |
|---|---|
Pyridoxine supplementation protects mice from suppression of contact hypersensitivity induced by 2-acetyl-4-tetrahydroxybutylimidazole (THI), ultraviolet B radiation (280-320 nm), or cis-urocanic acid.
Topics: Animals; Dermatitis, Contact; Diet; Imidazoles; Immunosuppressive Agents; Mice; Pyridoxine; Ultraviolet Rays; Urocanic Acid | 1995 |